HYPR Stock Analysis: Buy, Sell, or Hold?
HYPR - Hyperfine, Inc. Class A Common Stock
$1.47
-0.02 (-1.34%)
▼
5d:
+6.52%
30d:
-2.0%
90d:
+21.49%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When HYPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HYPR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: HYPR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: HYPR is currently trading at $1.47, which is considered fair relative to its 30-day fair value range of $1.40 to $1.56.
Technical Outlook: Technically, HYPR is in a strong uptrend. Immediate support is located at $1.38, while resistance sits at $1.70.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.17 (+47.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HYPR is in a strong uptrend. Immediate support is located at $1.38, while resistance sits at $1.70.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.17 (+47.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.40 -
$1.56
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 47.4% below Wall St target ($2.17)
Trading Range Analysis
30-Day Trading Range
$1.40 -
$1.56
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.38
Resistance Level
$1.70
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.32
Wall Street Target
$2.17
(+47.4%)
Revenue Growth (YoY)
82.6%
Profit Margin
-226.9%
Share & Embed Analysis
Last updated: June 23, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brett Hale
SELL
24188 shares
2026-03-23
Thomas Teisseyre
SELL
24188 shares
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
Advanced HYPR Option Strategies
Professional options setups generated by AI based on today's HYPR price and gamma walls.
